References
Trautmann A, Vivarelli M, Samuel S, Gipson D, Sinha A, Schaefer F, Hui NK, Boyer O, Saleem MA, Feltran L, Müller-Deile J, Becker JU, Cano F, Xu H, Lim YN, Smoyer W, Anochie I, Nakanishi K, Hodson E, Haffner D, International Pediatric Nephrology Association (2020) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 35:1529–1561. https://doi.org/10.1007/s00467-020-04519-1
Lee JM, Kronbichler A, Shin JI, Oh J (2021) Current understandings in treating children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 36:747–761. https://doi.org/10.1007/s00467-020-04476-9
Preston R, Stuart HM, Lennon R (2019) Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how? Pediatr Nephrol 34:195–210. https://doi.org/10.1007/s00467-017-3838-6
Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepherd K, Jones RC, Jaenisch R (1996) Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 122:3537–3547. https://doi.org/10.1242/dev.122.11.3537
Has C, Spartà G, Kiritsi D, Weibel L, Moeller A, Vega-Warner V, Waters A, He Y, Anikster Y, Esser P, Straub BK, Hausser I, Bockenhauer D, Dekel B, Hildebrandt F, Bruckner-Tuderman L, Laube GF (2012) Integrin α3 mutations with kidney, lung, and skin disease. N Engl J Med 366:1508–1514. https://doi.org/10.1056/NEJMoa1110813
Nicolaou N, Margadant C, Kevelam SH, Lilien MR, Oosterveld MJ, Kreft M, van Eerde AM, Pfundt R, Terhal PA, van der Zwaag B, Nikkels PG, Sachs N, Goldschmeding R, Knoers NV, Renkema KY, Sonnenberg A (2012) Gain of glycosylation in integrin α3 causes lung disease and nephrotic syndrome. J Clin Invest 122:4375–4387. https://doi.org/10.1172/JCI64100
Yalcin EG, He Y, Orhan D, Pazzagli C, Emiralioglu N, Has C (2015) Crucial role of posttranslational modifications of integrin α3 in interstitiallung disease and nephrotic syndrome. Hum Mol Genet 24:3679–3688. https://doi.org/10.1093/hmg/ddv111
He Y, Balasubramanian M, Humphreys N, Waruiru C, Brauner M, Kohlhase J, O’Reilly R, Has C (2016) Intronic ITGA3 mutation impacts splicing regulation and causes interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa. J Invest Dermatol 136:1056–1059. https://doi.org/10.1016/j.jid.2015.11.031
Colombo EA, Spaccini L, Volpi L, Negri G, Cittaro D, Lazarevic D, Zirpoli S, Farolfi A, Gervasini C, Cubellis MV, Larizza L (2016) Viable phenotype of ILNEB syndrome without nephrotic impairment in siblings heterozygous for unreported integrin alpha3 mutations. Orphanet J Rare Dis 11:136. https://doi.org/10.1186/s13023-016-0514-z
Tarur SU, Srinivasan S, Seeralar A (2020) Delayed presentation of respiratory symptoms and prolonged survival in homozygous a3 integrin deficiency. Indian Pediatr 57:268–269
Okamoto T, Nakamura A, Hayashi A, Yamaguchi T, Ogawa Y, Natsuga K, Yanagi K, Hotta K (2021) Successful kidney transplantation in a patient with neonatal-onset ILNEB. Pediatr Transplant 25:e13971. https://doi.org/10.1111/petr.13971
Cohen-Barak E, Danial-Farran N, Khayat M, Chervinsky E, Nevet JM, Ziv M, Shalev SA (2019) A nonjunctional, nonsyndromic case of junctional epidermolysis bullosa with renal and respiratory involvement. JAMA Dermatol 155:498–500. https://doi.org/10.1001/jamadermatol.2018.5368
Sondermann W, Büscher R, Forster H, Stehling F, Fischer J, He Y, Has C (2021) Skin fragility, renal malformation and interstitial lung disease due to compound heterozygous ITGA3 mutations. J Dtsch Dermatol Ges 19:899–901. https://doi.org/10.1111/ddg.14381
Alstrup M, Marks SD, Ek J, Buchvald F, Lund TK, Perch M, Waters AM, Mogensen M, Jelsig AM (2021) First patient with ILNEB syndrome due to pathogenic variants in ITGA3 surviving to adulthood. Eur J Med Genet 64:104335. https://doi.org/10.1016/j.ejmg.2021.104335
Kinyó Á, Kovács AL, Degrell P, Kálmán E, Nagy N, Kárpáti S, Gyulai R, Saeidian AH, Youssefian L, Vahidnezhad H, Uitto J (2021) Homozygous ITGA3 missense mutation in adults in a family with syndromic epidermolysis bullosa (ILNEB) without pulmonary involvement. J Invest Dermatol 141:2752–2756. https://doi.org/10.1016/j.jid.2021.03.029
Liu Y, Yue Z, Wang H, Li M, Wu X, Lin H, Han W, Lan S, Sun L (2021) A novel ITGA3 homozygous splice mutation in an ILNEB syndrome child with slow progression. Clin Chim Acta 523:430–436. https://doi.org/10.1016/j.cca.2021.10.027
Acknowledgements
The authors would like to acknowledge Dr. Ozden Bayazit from Central Washington University, WA, USA, for her proofreading.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This refers to the article that can be found at http://dx.doi.org/10.1007/s00467-022-05709-9.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Atmis, B., Cevizli, D., Cagli, C. et al. Nephrotic syndrome, skin involvement, and chronic lung disease: Answers. Pediatr Nephrol 38, 1481–1483 (2023). https://doi.org/10.1007/s00467-022-05711-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-022-05711-1